• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625315160
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/18/2021
Event Type  malfunction  
Manufacturer Narrative
The meter and test strips were requested for investigation.The product has not been received at this time.If the product is returned in the future, a follow-up report will be submitted.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods.".
 
Event Description
The initial reporter received questionable inr results with coaguchek xs plus meter serial number with (b)(4) compared to a laboratory using a stago neoplastin method.On (b)(6) 2021, the result from the meter was 3.8 inr.The result from the laboratory at the same time was 2.8 inr.On (b)(6) 2021, the result from the meter was 3.8 inr.The result from the laboratory at the same time was 2.7 inr.Both comparisons were for the same patient.The patient¿s therapeutic range is 2.0-3.0 inr.The quality controls were within range for both levels.
 
Manufacturer Narrative
The customer's returned meter powered on without difficulty using fresh retention batteries.The reporter's meter and test strips were provided for investigation where they were tested using retention controls.Vial #1 testing results (qc range = 2.4 - 3.6 inr): qc 1: 2.9 inr qc 2: 3.0 inr qc 3: 3.0 inr.Vial #2 testing results (qc range = 2.4 - 3.6 inr): qc 1: 3.0 inr qc 2: 3.0 inr qc 3: 3.0 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.The customer's power allegation could not be reproduced.The returned meter performed according to specification using fresh retention batteries.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key13120406
MDR Text Key287586882
Report Number1823260-2021-03949
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702128101
UDI-Public00365702128101
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2022
Device Catalogue Number04625315160
Device Lot Number54146311
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/21/2021
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/14/2021
Initial Date FDA Received12/30/2021
Supplement Dates Manufacturer Received01/18/2022
Supplement Dates FDA Received02/09/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ASPIRIN; CALCIUM; DIGOXIN; HYDROXYUREA; METOPROLOL; SELEXA; TRAZODONE; WARFARIN
Patient Age72 YR
Patient SexMale
Patient Weight90 KG
-
-